In a study conducted by Inaba et al. that utilized an in vivo xenograft ovarian cancer model, it was demonstrated that tumor progression was enhanced upon elevated expression of IDO because of its inhibitory effect on host immune cells. This evidence concerns the gene IDO1 and ovarian carcinoma.